Amidst a rare rewrite of the rules for sunscreen and with new Food and Drug Administration (FDA) findings in hand that reveal many of its ingredients can ‘seep into the bloodstream’ after twenty-four hours from application, U.S. Senator Charles Schumer is demanding the federal agency review all the active ingredients in sunscreen to determine which ingredients should be removed before ink on the new rules dries, which is set to occur in November of this year.
“There is no doubt about it: sunscreen has been a life-saver, but that doesn’t mean we can’t use the latest science and the best data to ensure that it is as safe as possible,” said U.S. Senator Charles Schumer. “That’s why, amidst the rare rewrite of sunscreen rules, where the FDA is looking into everything from packaging to protection, the one thing I am urging them to not get wrong and to move swiftly to address relates to the ingredients. We know very little about some of them and what they might do in our bloodstream, but we have the ability and the technology to find out.”
In February of 2019, the FDA announced its intention to update the regulatory requirements for most sunscreen products in the U.S. According to the FDA, the goal here is to “addresses sunscreen active ingredient safety, dosage forms, and sun protection factor (SPF) and broad-spectrum requirements.” The FDA also proposed updates to how products are labeled to make it easier for consumers to identify key product information.